Explaining the unexpected: insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel. Editorial on Serebruany "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5).
Thromb Haemost
; 105(5): 763-5, 2011 May.
Article
in En
| MEDLINE
| ID: mdl-21394382
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ticlopidine
/
Adenosine
/
Acute Coronary Syndrome
Type of study:
Guideline
Limits:
Humans
Country/Region as subject:
America do norte
/
Europa
Language:
En
Journal:
Thromb Haemost
Year:
2011
Document type:
Article
